ReviewFrontiers in pharmacology2020

miR-21, Mediator, and Potential Therapeutic Target in the Cardiorenal Syndrome.

Cheng-Kai Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.